Study finds emergency department visits jumped after valsartan recall

TORONTO — A large recall of contaminated medications appeared to spark confusion among many hypertension patients who were forced to give up the drug last year, with many turning to hospital emergency departments for medical help.

The non-profit group Institute for Clinical Evaluative Sciences says emergency department visits jumped 55 per cent among those affected by a Health Canada recall of some valsartan products.

Lead author Cynthia Jackevicius says that while the number of people who went to emergency was relatively small at just 0.17 per cent of affected patients, the increase was still significant.

The medications were taken off the market in July 2018 after they were found to contain an impurity known as NDMA, a potential carcinogen that can cause cancer with long-term exposure.

Researchers examined the impact on 55,461 affected patients and found that 10.7 per cent did not replace their medication within the three months that followed. Of those studied, 95 per cent had hypertension, while five per cent had heart failure. The average age was 76.

It wasn’t clear whether the emergency patients were among the 10 per cent who failed to replace their medication, or whether they went to hospital to get a new prescription, or lost control of their hypertension.

Jackevicius says the data suggests the need for better co-ordination between Health Canada, prescribers and pharmacists when a recall is announced.

“While government agencies issued advisories to continue taking medications until contacting their prescribers, there is a high potential for misunderstanding by patients, particularly given the mass media news that may have heightened the alarm regarding the potential negative consequences,” said the report, released Monday.

“Patients may have been willing to risk the short-term potential of uncontrolled hypertension to avoid ingesting a potential carcinogen.”

Before the recall, emergency room visits by the group studied averaged 0.11 per cent per month. In the month following the recall, the rate jumped to 0.17 per cent.

Researchers also found a delayed six per cent spike in emergency department visits for stroke patients taking valsartan, as well as an eight per cent jump in hospitalizations, but most of that jump did not appear until November.

Health Canada announced a voluntary recall of six generic valsartan products in July 2018 due to nitrosodimethylamine, or NDMA.

At the time, the federal agency urged those taking the affected medications to discuss treatment options with their health-care provider while the Canadian Pharmacists Association told affected patients they should not immediately stop their medication.

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

More choices now available for office locations in Red Deer

Depending on size, offices can locate in different city commercial zones

Painting of slain Red Deer doctor and his family is a reminder ‘we care’

Remembering the family of the late Dr. Walter Reynolds

COVID-19: More than 1 million Albertans have been tested to date

Roughly one in four Albertans have been tested

QUIZ: Do you know what’s on TV?

Fall is normally the time when new television shows are released

David Marsden: Molly Banister extension must be kept

‘It would be a mistake to take a sensible response to future residential development off the table’

Bubble hockey champs: Tampa Bay Lightning beat Dallas Stars 2-0, win Stanley Cup

Bubble hockey champs: Tampa Bay Lightning beat Dallas Stars 2-0, win Stanley Cup

Mahomes outplays Jackson to lead Chiefs past Ravens 34-20

Mahomes outplays Jackson to lead Chiefs past Ravens 34-20

The Finals are set: LeBron, Lakers will meet Butler, Heat

The Finals are set: LeBron, Lakers will meet Butler, Heat

Canadian Leylah Annie Fernandez upsets No. 31 seed at French Open

Canadian Leylah Annie Fernandez upsets No. 31 seed at French Open

Blue Jays to start Shoemaker in Game 1 against Rays, Ryu on tap in Game 2

Blue Jays to start Shoemaker in Game 1 against Rays, Ryu on tap in Game 2

Canadian men drawn with rival Americans in Group B at 2021 Gold Cup

Canadian men drawn with rival Americans in Group B at 2021 Gold Cup

Adesanya defends belt, Blachowicz wins title at UFC 253

Adesanya defends belt, Blachowicz wins title at UFC 253

Most Read